International Event

Join international researchers in a 2-day symposium on the role of cholesterol and other cardiovascular risk factors in Alzheimer's disease. Sessions will focus on epidemiology, clinical research and mechanistic studies.

More information may be found at www.cholesterolandalzheimer.com/index.aspx

This conference is presented by the Alzheimer's Drug Discovery Foundation and will bring together academic and industry researchers to accelerate the development of innovative drugs for the treatment of Alzheimer's disease and related dementias.

It is geared towards scientists, business development and licensing professionals, health management professionals, and venture capitalists.

For more information about the event, please visit www.worldeventsforum.com/addf/addrugdiscovery/index.html

Join international researchers in San Diego this Fall for the latest in drug development for Alzheimer's disease!

Topics of discussion for the scientific program and poster sessions will include:

--New Conceptual Models of Alzheimer's Disease;

--Infrastructure Needs for International Prevention Trials;

--Methodological Issues;

--Preventive and Disease-Modifying Trials;

--Validation of Biomarker and Clinical Outcome Measures for Prevention Trials;

--Others:  Health Economics and Quality of Life Issues

More information may be found at www.ctad.fr

Supported by the Queen Sofia Foundation and the Pasqual Maragall Foundation, Alzheimer's International 2011 will serve as a platform to present the latest findings in basic and clinical research, as well as in the areas of health and social care research.

More information may be found at www.alzheimerinternacional2011.org/alzheimers_international2011.html

This event is endorsed by the World Federation of Neurology, World Stroke Organization and the World Federation for NeuroRehabilitation, and will feature presentations by experts on the following main topics:

--Diagnosis, treatment & prevention of neurological diseases;

--Epidemiology of neurological diseases;

--Health service delivery, health policy and health economics;

--Translational neuroscience, improving outcomes for people with neurological disease

More information may be found at www.neuro-conference.com/2012/scientific/scientific-program.html

Sponsored by the Fundacon Ciudad de las Artes y las Ciencias - Comunitat Valenciana, international experts in learning, memory and cognitive function will discuss recent advances in the understanding of mechanisms involved in cognitive function, alterations in pathology, and the development of new therapeutic approaches for disorders including Alzheimer's disease and Parkinson's disease. More information may be found  at www.fundacioncac.es/eng/fundacion/actividades/actividadsympos.jsp?idActividad=112&tipo=1

The annual meeting will feature experts on the discussion of new developments in dementia, with a focus on cerebrovascular diseases affection cognition, and the overlap with Alzheimer's disease.

More information regarding the Congress may be found at www2.kenes.com/vascular2011/Pages/home.aspx

This Drug Discovery Summit, held as part of the 10th Annual World Pharma Congress, will feature invited speakers on a variety of topis related to Alzheimer's disease, including "Human Genetics", "Imaging & Biomarkers", "Animal Models" and "Targets".

More informationn regarding the conference may be found at www.worldpharmacongress.com/alz/

Supported by the Uppsala University, Uppsala University Hospital and the Swedish Research Council, the 2-day conference will present the latest findings on immunotherapy and biomarkers for a variety of neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis.

More information and a preliminary schedule of events may be found at

www-conference.slu.se/immunotherapyuppsala2011/index.html

Sponsored by the Institut Universitaire de Geriatrie de Montreal, the symposium will feature a variety of presentations on challenges related to treatment interventions for individuals with Alzheimer's disease.